These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2847677)

  • 1. [Correlation between 146S antigen dosage and antibody titers after foot-and-mouth disease vaccination in cattle and swine].
    Liebermann HT; Thalmann G; Nöckler A; Felfe P
    Arch Exp Veterinarmed; 1988 Jul; 42(4):528-36. PubMed ID: 2847677
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of virus infection-associated antigen and 3D antibodies in cattle vaccinated against foot and mouth disease.
    O'Donnell VK; Smitsaart E; Cetra B; Duffy S; Finelli J; Boyle D; Draghi G; Fondevila N; Schudel AA
    Rev Sci Tech; 1997 Dec; 16(3):833-40. PubMed ID: 9567309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation by heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle.
    Cartwright B; Chapman WG; Sharpe RT
    Res Vet Sci; 1982 May; 32(3):338-42. PubMed ID: 6179141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
    Ackermann M; Müller HK; Bruckner L; Kihm U
    Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of persistent aphthovirus infection and its differentiation from vaccination response in cattle by use of enzyme-linked immunoelectrotransfer blot analysis with bioengineered nonstructural viral antigens.
    Bergmann IE; de Mello PA; Neitzert E; Beck E; Gomes I
    Am J Vet Res; 1993 Jun; 54(6):825-31. PubMed ID: 8391765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. I. Screening tests and herd immunity].
    Müller HK; Villinger F; Griot C; Ackermann M; Bruckner L; Kihm U
    Schweiz Arch Tierheilkd; 1989; 131(7):379-86. PubMed ID: 2552579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of neonatal swine to inactivated foot-and-mouth disease virus vaccine with oil adjuvant. I. Influence of colostral antibody.
    Morgan DO; McKercher PD
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):244-55. PubMed ID: 220635
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemosynthetic peptides against foot-and-mouth disease--immune response to free and carrier bound peptides of the VP1 of O1-Kaufbeuren].
    Liebermann H; Reimann I; Bartels T; Nöckler A; Thalmann G; Furkert J; Dölling R
    Arch Exp Veterinarmed; 1990; 44(2):189-97. PubMed ID: 1696803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intranasal vaccination of cattle against foot-and-mouth disease].
    Bauer K; Straub OC
    Berl Munch Tierarztl Wochenschr; 1985 Jul; 98(7):247-50. PubMed ID: 2994624
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response in bovine pharyngeal fluid following foot-and-mouth disease vaccination and, or, exposure to live virus.
    Francis MJ; Ouldridge EJ; Black L
    Res Vet Sci; 1983 Sep; 35(2):206-10. PubMed ID: 6314460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.
    McKercher PD; Moore DM; Morgan DO; Robertson BH; Callis JJ; Kleid DG; Shire SJ; Yansura DG; Dowbenko D; Small B
    Am J Vet Res; 1985 Mar; 46(3):587-90. PubMed ID: 2986495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of vaccination against foot-and-mouth disease on results of the immunodiffusion test for the demonstration of precipitating bovine leukosis virus antibodies].
    Straub OC
    Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):135-7. PubMed ID: 6305624
    [No Abstract]   [Full Text] [Related]  

  • 13. Revaccination response of cattle as a function of the 140S foot and mouth disease antigen dose.
    Black L; Rweyemamu M; Boge A
    J Comp Pathol; 1984 Jul; 94(3):417-24. PubMed ID: 6088598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development and use of laboratory procedures in assessing the effectiveness of foot-and-mouth disease vaccines for cattle and swine].
    Thalmann G; Nöckler A; Felfe P; Kreienbrink G
    Arch Exp Veterinarmed; 1987 Nov; 41(6):806-11. PubMed ID: 2831828
    [No Abstract]   [Full Text] [Related]  

  • 15. Foot-and-mouth disease: a vaccine study.
    McKercher PD; Callis JJ
    Dev Biol Stand; 1976; 35():123-33. PubMed ID: 198278
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.
    Pay TW; Hingley PJ
    Vaccine; 1987 Mar; 5(1):60-4. PubMed ID: 3033928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic relations between the foot-and-mouth disease virus isolates A5 Westerwald 1951 and A5 Bernbeuren 1984].
    Bengelsdorff HJ
    Berl Munch Tierarztl Wochenschr; 1987 Aug; 100(8):264-8. PubMed ID: 2820373
    [No Abstract]   [Full Text] [Related]  

  • 18. Residual foot-and-mouth disease virus antibodies in French cattle and sheep six years after the vaccination ban.
    Remond M; Kaiser C; Lebreton FO; Moutou F; Crucière C
    Vet Res; 2001; 32(1):81-6. PubMed ID: 11254180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.
    Cartwright B; Chapman WG; Brown F
    J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of effectiveness of FMD vaccine type Asia 1 in neutralization tests in cattle].
    Dimitriadis IA
    Berl Munch Tierarztl Wochenschr; 1993 Apr; 106(4):124-7. PubMed ID: 8387775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.